TechCrunch Industry News Lindus Health raises $55M to ‘fix the broken clinical trial industry’
Jan 24, 2025
A London startup has secured $55 million to tackle the challenges of the clinical trial industry. Backed by Peter Thiel, they're leveraging artificial intelligence to revolutionize drug discovery and development. This innovative approach emphasizes automation and efficiency, aiming to reshape the biotech landscape. The focus on improving clinical trials highlights a critical shift in how healthcare can evolve with cutting-edge technology.
AI Snips
Chapters
Transcript
Episode notes
Fixing the Broken Clinical Trial Industry
- Lindus Health, backed by Peter Thiel, raises $55M to improve clinical trials.
- They aim to streamline the process and get medicines to market faster.
Lindus Health's Approach
- Lindus Health uses machine learning to design initial protocols, which are labor-intensive.
- They offer full end-to-end clinical trial services, including staff.
Lindus Health's Focus
- Lindus Health has conducted trials across Europe and the U.S. for conditions like asthma, acne, and chronic fatigue syndrome.
- They focus on complex and prevalent conditions often neglected by the industry.